Significance of cyclooxygenase-2 in prognosis, targeted therapy and chemoprevention of NSCLC

JM Lee, JT Mao, K Krysan, SM Dubinett - Future Oncology, 2007 - Taylor & Francis
Evaluation of: Tsubochi H, Nobuyuki S, Hiyama M et al.: Combined analysis of
cyclooxygenase-2 expression with p53 and Ki-67 in nonsmall cell lung cancer. Ann. Thorac …

Significance of cyclooxygenase-2 in prognosis, targeted therapy and chemoprevention of NSCLC

JM Lee, JT Mao, K Krysan, SM Dubinett - Future Oncology, 2007 - go.gale.com
The report by Tsubochi and colleagues adds to the growing body of evidence supporting the
multi-faceted role of cyclooxygenase (Cox)-2 in non-small-cell lung cancer (NSCLC) and its …

Significance of cyclooxygenase-2 in prognosis, targeted therapy and chemoprevention of NSCLC.

JM Lee, JT Mao, K Krysan… - Future Oncology (London …, 2007 - europepmc.org
Significance of cyclooxygenase-2 in prognosis, targeted therapy and chemoprevention of
NSCLC. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu …

Significance of cyclooxygenase-2 in prognosis, targeted therapy and chemoprevention of NSCLC

JM Lee, JT Mao, K Krysan… - Future oncology …, 2007 - pubmed.ncbi.nlm.nih.gov
The report by Tsubochi and colleagues adds to the growing evidence indicating that tumor
cyclo-oxygenase (Cox)-2 has a multifaceted role in conferring the malignant phenotype of …

Significance of cyclooxygenase-2 in prognosis, targeted therapy and chemoprevention of NSCLC

JM Lee, JT Mao, K Krysan, SM Dubinett - Future Oncology, 2007 - search.proquest.com
Abstract Evaluation of: Tsubochi H, Nobuyuki S, Hiyama M et al.: Combined analysis of
cyclooxygenase-2 expression with p53 and Ki-67 in nonsmall cell lung cancer. Ann. Thorac …